Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 15 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-0.60 Insider Own27.30% Shs Outstand167.43M Perf Week-3.10%
Market Cap209.93M Forward P/E- EPS next Y-0.45 Insider Trans-1.72% Shs Float122.08M Perf Month49.18%
Income-101.17M PEG- EPS next Q-0.15 Inst Own35.96% Short Float10.10% Perf Quarter52.42%
Sales0.00M P/S- EPS this Y20.80% Inst Trans67.22% Short Ratio5.36 Perf Half Y41.84%
Book/sh0.31 P/B4.10 EPS next Y0.63% ROA-66.81% Short Interest12.33M Perf Year2.46%
Cash/sh0.68 P/C1.83 EPS next 5Y- ROE-161.67% 52W Range0.57 - 2.58 Perf YTD49.08%
Dividend Est.- P/FCF- EPS past 5Y73.95% ROI-93.43% 52W High-51.46% Beta0.46
Dividend TTM- Quick Ratio5.34 Sales past 5Y-20.00% Gross Margin- 52W Low118.42% ATR (14)0.13
Dividend Ex-Date- Current Ratio5.34 EPS Y/Y TTM67.74% Oper. Margin0.00% RSI (14)52.01 Volatility12.94% 12.43%
Employees93 Debt/Eq1.14 Sales Y/Y TTM- Profit Margin- Recom1.33 Target Price3.55
Option/ShortYes / Yes LT Debt/Eq1.12 EPS Q/Q66.69% Payout- Rel Volume0.94 Prev Close1.34
Sales Surprise- EPS Surprise31.37% Sales Q/Q- EarningsMar 21 BMO Avg Volume2.30M Price1.25
SMA20-3.01% SMA5017.41% SMA20014.48% Trades Volume2,166,699 Change-6.72%
Date Action Analyst Rating Change Price Target Change
Dec-12-23Downgrade B. Riley Securities Buy → Neutral $3 → $1
Aug-30-23Resumed B. Riley Securities Buy $3
Dec-22-22Initiated Cantor Fitzgerald Overweight $3
Dec-12-22Initiated Piper Sandler Overweight $3
Dec-23-19Initiated Oppenheimer Outperform $20
Dec-18-19Initiated ROTH Capital Buy $20
Dec-09-19Upgrade Citigroup Neutral → Buy $16 → $20
Dec-05-19Initiated B. Riley FBR Buy
Jun-07-19Initiated Stifel Buy $27
Jun-05-19Initiated Cowen Outperform
Apr-02-24 04:05PM
Apr-01-24 08:00AM
Mar-22-24 12:47PM
Mar-21-24 10:09PM
09:11AM Loading…
Mar-12-24 08:00AM
Mar-01-24 04:05PM
Feb-01-24 04:05PM
Dec-09-23 12:00PM
Dec-04-23 04:05PM
Nov-10-23 03:46PM
09:29AM Loading…
Nov-09-23 09:29AM
Nov-02-23 08:00AM
Nov-01-23 04:05PM
Oct-31-23 08:00AM
Oct-18-23 08:00AM
Oct-02-23 04:05PM
Sep-19-23 08:00AM
Sep-06-23 08:00AM
Sep-05-23 08:00AM
Sep-01-23 04:05PM
Aug-15-23 10:53AM
Aug-10-23 06:38AM
Aug-08-23 04:05PM
08:00AM Loading…
Aug-03-23 08:00AM
Aug-02-23 08:01AM
Jun-30-23 04:05PM
Jun-14-23 06:26AM
Jun-13-23 08:00AM
Jun-02-23 04:05PM
May-16-23 04:01PM
May-15-23 04:44AM
May-04-23 06:12AM
Apr-26-23 12:32PM
Apr-12-23 08:00AM
Apr-04-23 04:05PM
Mar-24-23 07:36AM
Mar-21-23 06:05AM
Mar-07-23 08:01AM
Mar-02-23 04:05PM
Jan-31-23 12:00PM
Dec-12-22 08:30AM
Dec-07-22 08:43AM
Dec-06-22 06:26PM
Nov-30-22 08:05AM
Nov-29-22 04:01PM
Nov-17-22 09:51AM
Nov-08-22 08:00AM
Nov-04-22 04:05PM
Nov-03-22 06:05AM
Oct-26-22 08:00AM
Oct-20-22 08:00AM
Sep-27-22 10:49AM
Aug-31-22 08:30AM
Aug-18-22 12:00PM
Aug-08-22 04:05PM
Aug-04-22 07:05AM
Jul-26-22 04:05PM
Jul-21-22 02:46PM
Jul-20-22 04:10PM
Jul-01-22 04:30PM
Jun-30-22 07:52PM
Jun-23-22 07:00AM
May-16-22 06:05AM
May-12-22 07:15AM
May-03-22 06:05AM
May-02-22 04:05PM
Apr-08-22 01:05PM
Apr-04-22 08:05AM
Apr-01-22 04:05PM
Mar-17-22 06:05AM
Mar-08-22 08:00AM
Mar-03-22 08:00AM
Mar-01-22 10:15AM
Feb-02-22 04:05PM
Jan-19-22 08:00AM
Jan-05-22 04:05PM
Dec-13-21 12:52PM
Dec-11-21 09:00AM
Dec-02-21 06:05AM
Dec-01-21 04:05PM
Nov-10-21 08:00AM
Nov-04-21 09:01AM
Nov-01-21 04:05PM
Oct-25-21 08:00AM
Oct-19-21 08:00AM
X4 Pharmaceuticals, Inc. is a late clinical-stage company, which engages in the development and discovery of novel therapeutics for the treatment of rare diseases and those with limited treatment options. Its clinical candidate is mavorixafor. The company was founded by Henri A. Termeer, Keith T. Flaherty, Renato T. Skerlj, Richard Peters and Paula Ragan in 2010 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mostafa Adam S.Chief Financial OfficerMar 11 '24Sale0.8852,50046,3470Mar 11 05:19 PM
Ragan PaulaPresident and CEOMar 11 '24Sale0.8849,67843,856765,068Mar 11 05:20 PM
DiBiase MaryChief Operating OfficerMar 11 '24Sale0.8815,40913,591291,752Mar 11 05:19 PM
Taveras ArthurChief Scientific OfficerMar 11 '24Sale0.8814,23512,552234,301Mar 11 05:20 PM
Mostafa Adam S.Chief Financial OfficerFeb 12 '24Sale1.0127,72127,97352,500Feb 12 05:03 PM
Ragan PaulaPresident and CEOFeb 12 '24Sale1.0121,69521,892814,746Feb 12 05:05 PM
DiBiase MaryChief Operating OfficerFeb 12 '24Sale1.013,6833,709307,161Feb 12 05:23 PM
Taveras ArthurChief Scientific OfficerFeb 12 '24Sale1.01787793248,536Feb 12 05:23 PM
Ragan PaulaPresident and CEONov 03 '23Sale0.9039,90635,915836,441Nov 03 05:26 PM
Mostafa Adam S.Chief Financial OfficerNov 01 '23Sale0.73230,645168,37180,221Nov 03 04:42 PM
Ragan PaulaPresident and CEONov 01 '23Sale0.73199,531145,658876,347Nov 03 05:26 PM
DiBiase MaryChief Operating OfficerNov 01 '23Sale0.7367,69549,417310,844Nov 03 04:40 PM
Taveras ArthurChief Scientific OfficerNov 01 '23Sale0.7367,69549,417249,323Nov 03 04:39 PM
Baldry MarkChief Commercial OfficerNov 01 '23Sale0.7310,2577,48824,690Nov 03 04:39 PM
DiBiase MaryChief Operating OfficerSep 08 '23Sale1.252,6423,300147,894Sep 12 04:04 PM
WYZGA MICHAEL SDirectorAug 18 '23Buy1.2025,00029,87576,667Aug 22 04:09 PM
Stewart MurrayInterim Chief Medical OfficerAug 10 '23Sale1.06130,056137,859146,504Aug 11 07:26 PM
Mostafa Adam S.Chief Financial OfficerJun 30 '23Sale1.892,6414,99180,221Jul 05 04:04 PM
DiBiase MaryChief Operating OfficerJun 30 '23Sale1.89464877150,536Jul 05 04:05 PM
Ragan PaulaPresident and CEOJun 23 '23Sale1.926,72412,910543,797Jun 26 04:11 PM
Mostafa Adam S.Chief Financial OfficerJun 23 '23Sale1.935,41710,45582,862Jun 26 04:13 PM
DiBiase MaryChief Operating OfficerJun 23 '23Sale1.938571,654151,000Jun 26 04:15 PM
Ragan PaulaPresident and CEOJun 15 '23Sale2.236,72414,995550,521Jun 16 04:15 PM
Mostafa Adam S.Chief Financial OfficerJun 15 '23Sale2.225,41712,02688,279Jun 16 04:17 PM
DiBiase MaryChief Operating OfficerJun 15 '23Sale2.238571,911151,857Jun 16 04:24 PM
Ragan PaulaPresident and CEOMay 31 '23Sale1.956,29212,269557,245May 31 05:05 PM